Anavex receives FDA go-ahead for clinical study
- FDA allows clinical study for blarcamesine in Fragile X syndrome
- Press release dated October 15, 2026
- Exhibit 99.1 includes the press release
Every EDGAR filing for ANAVEX LIFE SCIENCES CORP. (AVXL), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 25 ยท 10-K expected ~Dec 7 (deadline Nov 30)
No open-market insider buys in the last 30 days.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Gautam Patel, new insider at AVXL
Gautam Patel
Sandra Boenisch, insider filing for AVXL
Sandra Boenisch, reporting
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
PVG ASSET MANAGEMENT CORP, filed by
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
PVG ASSET MANAGEMENT CORP, filed by
Terrie Kellmeyer, new insider at AVXL
Terrie Kellmeyer, reporting
Axel Paeger, new insider at AVXL
Axel Paeger, reporting
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by